V9G0 Stock Chart & Stats
€1.43
€0.00(0.00%)
At close: 4:00 PM EDT
€1.43
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.42 - €1.43
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€6.90M
Enterprise Value€14.45
Total Cash (Recent Filing)€11.78M
Total Debt (Recent Filing)€7.29M
Price to Earnings (P/E)―
Beta-0.53
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.29
Shares Outstanding8,589,266
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.07
Price to Sales (P/S)0.05
P/FCF Ratio-0.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strategic SimplificationThe divestiture could simplify operations, reduce exposure to weaker airport businesses and provide capital for the remaining wellness platform. Its benefit depends on buyer financing, approvals and closing, but it represents a potentially durable portfolio reset.
Gross Margin ResilienceMaintaining gross margin in the mid-20% range indicates the services can retain some economic value despite declining revenue. If management reduces operating costs and focuses the portfolio, this margin base could support improved earnings over time.
Governance And Strategic ExpertiseAdding a director with infrastructure and capital-markets experience may strengthen oversight during the divestiture and strategic repositioning. The CEO’s board departure also allows greater focus on operations, although execution benefits are not yet demonstrated.
Bears Say
Persistent Operating LossesSevere operating losses show that current revenue is insufficient to cover the company’s cost base. Unless restructuring produces substantial savings or the retained businesses grow, losses can continue consuming capital and weaken the company’s ability to invest.
Revenue ContractionDeclining revenue indicates weakening demand, a contracting footprint or both, reducing operating leverage and limiting the path to profitability. A smaller revenue base also makes fixed costs harder to absorb and increases dependence on successful strategic execution.
Cash Burn And Fragile Balance SheetNegative operating and free cash flow means the business is not self-funding, while very thin equity provides little protection against further losses. Continued external financing, asset sales or cost cuts may be required, limiting financial flexibility.
XWELL News
V9G0 FAQ
What was XWELL’s price range in the past 12 months?
XWELL lowest stock price was €1.42 and its highest was €1.43 in the past 12 months.
What is XWELL’s market cap?
XWELL’s market cap is €6.90M.
When is XWELL’s upcoming earnings report date?
XWELL’s upcoming earnings report date is Nov 18, 2026 which is in 91 days.
How were XWELL’s earnings last quarter?
XWELL released its earnings results on Aug 17, 2026. The company reported -€0.228 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is XWELL overvalued?
According to Wall Street analysts XWELL’s price is currently Overvalued.
Does XWELL pay dividends?
XWELL does not currently pay dividends.
What is XWELL’s EPS estimate?
XWELL’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XWELL have?
XWELL has 8,589,266 shares outstanding.
What happened to XWELL’s price movement after its last earnings report?
XWELL reported an EPS of -€0.228 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of XWELL?
Currently, no hedge funds are holding shares in DE:V9G0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
XWELL
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Technical Analysis
Medifast
―
Regis
―
MEDIROM Healthcare Technologies
―
E-Home Household Service Holdings
―
Interactive Strength Inc
―